Circulation. 2003;107:443-447
Published online before print January 6, 2003, doi: 10.1161/01.CIR.0000045669.16499.EC
Published online before print January 6, 2003, doi: 10.1161/01.CIR.0000045669.16499.EC
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:443.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Alcohol Consumption and Plasma Concentration of C-Reactive Protein
From the Center for Cardiovascular Disease Prevention and the Leducq Center for Cardiovascular Research, Divisions of Cardiovascular Diseases and of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Dr Michelle A. Albert, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail maalbert{at}partners.org
Background— Moderate alcohol intake has been associated with lower cardiovascular mortality. However, data evaluating the relationship between C-reactive protein (CRP), a predictor of cardiovascular risk, and alcohol consumption are sparse.
Methods and Results— The relationship between alcohol consumption and CRP was evaluated in a cross-sectional survey and over time among 1732 men and 1101 women participating in the Pravastatin Inflammation/CRP Evaluation Study. CRP levels were lower in those with moderate alcohol intake versus light or occasional intake: in 5 categories of alcohol intake (no alcohol or <1 drink monthly, 1 to 3 drinks monthly, 1 to 4 drinks weekly, 5 to 7 drinks weekly, and 
2 drinks daily), median CRP levels were 2.60 mg/L (interquartile range (IQR), 1.20 to 5.30 mg/L), 2.20 mg/L (IQR, 1.00 to 4.40 mg/L), 1.70 mg/L (IQR, 0.80 to 3.80 mg/L), 1.60 mg/L (IQR, 0.80 to 3.30 mg/L), and 1.80 mg/L (IQR, 0.80 to 2.90 mg/L), respectively. This relationship was present among men, women not taking hormone replacement therapy, nonsmokers, and those individuals with and without a history of cardiovascular disease (all P<0.001). In multivariate analysis, the relationship between alcohol consumption and CRP remained significant after controlling for multiple traditional cardiovascular risk factors. Alcohol consumption did not significantly affect the change in CRP or lipid levels associated with statin use.
Conclusion— Moderate alcohol consumption was associated with lower CRP concentrations than no or occasional alcohol intake, an effect that was independent of alcohol-related effects on lipids. Alcohol may attenuate cardiovascular mortality in part through an anti-inflammatory mechanism.
Key Words: alcohol • protein, C-reactive • inflammation
This article has been cited by other articles:
 |
|
 |
|
  R. J. Glynn, J. G. MacFadyen, and P. M Ridker Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study Clin. Chem., February 1, 2009; 55(2): 305 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Imhof, R. Blagieva, N. Marx, and W. Koenig Drinking modulates monocyte migration in healthy subjects: a randomised intervention study of water, ethanol, red wine and beer with or without alcohol Diabetes and Vascular Disease Research, March 1, 2008; 5(1): 48 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Sacanella, M. Vazquez-Agell, M. P. Mena, E. Antunez, J. Fernandez-Sola, J. M. Nicolas, R. M Lamuela-Raventos, E. Ros, and R. Estruch Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1463 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. O'Keefe, K. A. Bybee, and C. J. Lavie Alcohol and Cardiovascular Health: The Razor-Sharp Double-Edged Sword J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1009 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J Mukamal, N. S Jenny, R. P Tracy, and D. S Siscovick Alcohol consumption, interleukin-6 and apolipoprotein E genotypes, and concentrations of interleukin-6 and serum amyloid P in older adults Am. J. Clinical Nutrition, August 1, 2007; 86(2): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szabo, A. Dolganiuc, Q. Dai, and S. B. Pruett TLR4, Ethanol, and Lipid Rafts: A New Mechanism of Ethanol Action with Implications for other Receptor-Mediated Effects J. Immunol., February 1, 2007; 178(3): 1243 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Gigleux, J. Gagnon, A. St-Pierre, B. Cantin, G. R. Dagenais, F. Meyer, J.-P. Despres, and B. Lamarche Moderate Alcohol Consumption Is More Cardioprotective in Men with the Metabolic Syndrome J. Nutr., December 1, 2006; 136(12): 3027 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Giugliano, A. Ceriello, and K. Esposito The Effects of Diet on Inflammation: Emphasis on the Metabolic Syndrome J. Am. Coll. Cardiol., August 15, 2006; 48(4): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Femia, A. Natali, A. L'Abbate, and E. Ferrannini Coronary Atherosclerosis and Alcohol Consumption: Angiographic and Mortality Data Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1607 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Wright, M. S.V. Elkind, T. Rundek, B. Boden-Albala, M. C. Paik, and R. L. Sacco Alcohol Intake, Carotid Plaque, and Cognition: The Northern Manhattan Study Stroke, May 1, 2006; 37(5): 1160 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K Kabagambe, A. Baylin, E. Ruiz-Narvaez, E. B Rimm, and H. Campos Alcohol intake, drinking patterns, and risk of nonfatal acute myocardial infarction in Costa Rica Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1336 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. F. Wilson, B.-H. Nam, M. Pencina, R. B. D'Agostino Sr, E. J. Benjamin, and C. J. O'Donnell C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study Arch Intern Med, November 28, 2005; 165(21): 2473 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Doi, Y. Kiyohara, M. Kubo, T. Ninomiya, Y. Wakugawa, K. Yonemoto, M. Iwase, and M. Iida Elevated C-Reactive Protein Is a Predictor of the Development of Diabetes in a General Japanese Population: The Hisayama Study Diabetes Care, October 1, 2005; 28(10): 2497 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Boffetta Alcohol and lung cancer: do we have the answers? Am. J. Clinical Nutrition, September 1, 2005; 82(3): 495 - 496. [Full Text] [PDF]
|
|
|
|
|
|
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members Stroke, June 1, 2005; 36(6): 1316 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Szmitko and S. Verma Antiatherogenic potential of red wine: clinician update Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2023 - H2030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Schmidt, D. J. Libon, F. Pezzetta, L. Mascitelli, G. Zuccala, E. Marzetti, R. Bernabei, M. J. Stampfer, J. H. Kang, and F. Grodstein Alcohol and Cognitive Function in Older Women N. Engl. J. Med., April 28, 2005; 352(17): 1817 - 1819. [Full Text] [PDF]
|
|
|
|
 |
|
 L. RETTERSTOL, K. E. BERGE, O. BRAATEN, L. EIKVAR, T. R. PEDERSEN, and L. SANDVIK A DAILY GLASS OF RED WINE: DOES IT AFFECT MARKERS OF INFLAMMATION? Alcohol Alcohol., March 1, 2005; 40(2): 102 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Greenfield, K. Samaras, C. S. Hayward, D. J. Chisholm, and L. V. Campbell Beneficial Postprandial Effect of a Small Amount of Alcohol on Diabetes and Cardiovascular Risk Factors: Modification by Insulin Resistance J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 661 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Myers, N. Rifai, R. P. Tracy, W. L. Roberts, R. W. Alexander, L. M. Biasucci, J. D. Catravas, T. G. Cole, G. R. Cooper, B. V. Khan, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Laboratory Science Discussion Group Circulation, December 21, 2004; 110(25): e545 - e549. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Imhof, M. Woodward, A. Doering, N. Helbecque, H. Loewel, P. Amouyel, G.D.O. Lowe, and W. Koenig Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille) Eur. Heart J., December 1, 2004; 25(23): 2092 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Niroomand, O Hauer, C P Tiefenbacher, H A Katus, and W Kuebler Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation Heart, October 1, 2004; 90(10): 1189 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mascitelli and F. Pezzetta Alcohol Use and Diabetes Mellitus Ann Intern Med, September 7, 2004; 141(5): 409 - 409. [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Suarez C-Reactive Protein Is Associated With Psychological Risk Factors of Cardiovascular Disease in Apparently Healthy Adults Psychosom Med, September 1, 2004; 66(5): 684 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. ALHO, P. SILLANAUKEE, A. KALELA, O. JAAKKOLA, S. LAINE, and S. T. NIKKARI ALCOHOL MISUSE INCREASES SERUM ANTIBODIES TO OXIDIZED LDL AND C-REACTIVE PROTEIN Alcohol Alcohol., July 1, 2004; 39(4): 312 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Greenfield, K. Samaras, A. B. Jenkins, P. J. Kelly, T. D. Spector, J. R. Gallimore, M. B. Pepys, and L. V. Campbell Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences Circulation, June 22, 2004; 109(24): 3022 - 3028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. A. Ajani, E. S. Ford, and A. H. Mokdad Dietary Fiber and C-Reactive Protein: Findings from National Health and Nutrition Examination Survey Data J. Nutr., May 1, 2004; 134(5): 1181 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M de Lorgeril and P Salen Is alcohol anti-inflammatory in the context of coronary heart disease? Heart, April 1, 2004; 90(4): 355 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Humphries, P. M. Ridker, and P. J. Talmud Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation? Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 628 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mascitelli and F. Pezzetta Anti-Inflammatory Action of Alcohol and Risk of Type 2 Diabetes Mellitus Arch Intern Med, March 8, 2004; 164(5): 572 - 572. [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford, W. H. Giles, A. H. Mokdad, and G. L. Myers Distribution and Correlates of C-Reactive Protein Concentrations among Adult US Women Clin. Chem., March 1, 2004; 50(3): 574 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Volpato, M. Pahor, L. Ferrucci, E. M. Simonsick, J. M. Guralnik, S. B. Kritchevsky, R. Fellin, and T. B. Harris Relationship of Alcohol Intake With Inflammatory Markers and Plasminogen Activator Inhibitior-1 in Well-Functioning Older Adults: The Health, Aging, and Body Composition Study Circulation, February 10, 2004; 109(5): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.M. Hirschfield and M.B. Pepys C-reactive protein and cardiovascular disease: new insights from an old molecule QJM, November 1, 2003; 96(11): 793 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mascitelli and F. Pezzetta Anti-inflammatory Effects of Alcohol Arch Intern Med, October 27, 2003; 163(19): 2393 - 2393. [Full Text] [PDF]
|
|
|
|
|
|
T. B. Ledue and N. Rifai Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment Clin. Chem., August 1, 2003; 49(8): 1258 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Kroenke, N.-F. Chu, N. Rifai, D. Spiegelman, S. E. Hankinson, J. E. Manson, and E. B. Rimm A Cross-Sectional Study of Alcohol Consumption Patterns and Biologic Markers of Glycemic Control Among 459 Women Diabetes Care, July 1, 2003; 26(7): 1971 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kreisberg and A. Oberman Medical Management of Hyperlipidemia/Dyslipidemia J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2445 - 2461. [Full Text] [PDF]
|
|